Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $277.00, but opened at $299.45. Bio-Rad Laboratories shares last traded at $299.45, with a volume of 75 shares traded.
Bio-Rad Laboratories Price Performance
The company has a quick ratio of 4.19, a current ratio of 5.62 and a debt-to-equity ratio of 0.16. The company has a market cap of $8.08 billion, a PE ratio of 10.73 and a beta of 0.98. The stock has a 50-day moving average of $272.41 and a 200-day moving average of $294.77.
Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported $2.51 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a return on equity of 3.86% and a net margin of 29.42%.The company had revenue of $693.20 million for the quarter.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad’s product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.
In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.
Read More
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
